The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

BACKGROUND: Mantle cell lymphoma (MCL) is an incurable B cell-derived malignant tumor with a median overall survival of 4–5 years. Mer tyrosine kinase (MerTK) has been reported to be aberrantly expressed in leukemia, melanoma, and gastric cancer, and plays a pivotal role in the process of oncogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Cunzhen, Li, Xiangqun, Wang, Xiaogan, Ding, Ning, Ping, Lingyan, Shi, Yunfei, Mi, Lan, Lai, Yumei, Song, Yuqin, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859520/
https://www.ncbi.nlm.nih.gov/pubmed/29554921
http://dx.doi.org/10.1186/s13045-018-0584-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859520/
https://www.ncbi.nlm.nih.gov/pubmed/29554921
http://dx.doi.org/10.1186/s13045-018-0584-6

Ejemplares similares